Hemagglutinin-binding peptide
US10328143B2 · kind B2 · utility
0Cited by
2References
11Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 23, 2015 |
| Grant date | Jun 25, 2019 |
| Priority date | — |
| Expiry date | Nov 25, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K19/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Object of the present invention is to provide a hemagglutinin-binding peptide producing an anti-influenza virus effect higher than that of existing peptides. The present invention provides, for example, a hemagglutinin-binding peptide comprising a polypeptide having any of the following amino acid sequences (i) to (iv):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.